false
OasisLMS
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Skip Navigation Links
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Menu
EDU360 Home
IGCS Website
IGCS Profile
Education360 Information
Membership
FAQ
International Journal of Gynecological Cancer
Hamburger Menu
Catalog
Calendar
Help
Catalog
Study 309/Keynote-775: A Randomized, Phase 3 Study ...
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
Description
Recorded Live: May 10, 2022
Presenter
Vicky Makker, MD
USA
Summary
Availability:
On-Demand
Cost:
FREE
×
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
Multidisciplinary Approach to Treating Advanced Endometrial Cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
An Evolving Frontier: Endometrial Cancer Treatment
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Surgery for Early Cervical Cancer: Current Key Aspects
Master Session held at IGCS 2023 in Seoul.
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
IGCS 2024 Endometrial Cancer Master Session
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
IGCS 2024 Cervical Master Sessions: Moving Forwards
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Journal Club:Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE)
FREE
Login
User Login
Continue with Google
OR
Login Name
Required
Password
Required
Logging In…
Create Account
Forgot Password
×